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Microemboli in the blood of extracorporeal perfusion system was studied and the follow-
ing results were obtained. 
( 1 ) A part of microemboli in the extracorporeal circulation blood originated in priming 
stored blood. 
( 2) Heparinized blood contained more micromboli than citrated blood. There was some 
statistical inverse correlation between emboli volume and platelet count. (r二一0.684)
( 3) In recirculation circuit (in vitro), there was a large amount of microemboli formation 
at the time when blood passed through the bubble oxygenator, however, this phenomenon was 
observed only in the first stage of oxygenation, five minutes after start of oxyg巴nation,there 
was a tendency to diminution of microemboli volume. 
In membrane oxygenator, there was a litle emboli formation. The rate of drop in the 
platelet count during the oxygenation was seen markedly in bubble oxygenator, however, 
after sixty minutes of oxygenation, there was no significant differ巴ncein the rate between 
membrane type and bubble typ巴 oxygenation.
( 4) The composition of the microemboli was evaluated by scanning electron microscopy, 
thin layer chromatography (Lipid), PT AH stain and Sudan III stain. 
The emboli were mainly composed of platelet-aggregates and it contained phospholipid 
and cholesterol, howe,・er, in the emboli that collected from the blood of the cir℃uits during 
the assisted perfusion in cases of the patients as well as the dogs, there was appearance of 
a litle triglyceride, on the other hand, in total perfusion with cardiotomy suction, the 
microemboli came to contain a great deal of triglyceride. 
( 5 ) The change of巴mbolivolume during cardiopulmonary bypass (in vivo) was de-
tected by SFP method. The following results were obtained. 
(A) Microemboli volume increased markedly immediately after bypass start, and after 
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five minutes of it, the volume fel below the control level. Making a comparison between 
bubble and membrane type oxygenator group, there was a highly significant increase 
CP<O. 005) in emboli volume in the former group. 
(B) During the bypass, the arterial line blood contained more emboli than the venous 
line blood. There was a significant difference CP<O. 05), and bubble oxygenator 
group had more emboli than membrane oxygenator group in the arterial line blood. 
These phenomena showed the fact that these microemboli were continuously produced 
during the bypass and filtrated in the capillary beds. 
( 6 ) After bypass, the recovery rate of platelet count was better in the membrane ox-
ygenator group, after six postoperative hours. 
The recovery of platelet adhesiveness was better in membrane oxygenator group after five 
postoperative hours. 
( 7 ) In the small arteries of dogs' kindney that was sacrificed immediately after assi-
sted perfusion, microembolism was observed more frequently in the bubble oxygenator 
group. This emboli stained strongly by Sudan II. 
( 8) The hemolytic plasma that was obtained from bubble oxygenation promoted the 
aggregation of platelets when added to fresh blood and formed microemboli. There was a 













































体外循環中に生じる Microemboliに関する研究 339 
血液を計6回採取し． ζの血液は夫々直ちにへパリン













定した． 即ちSwinnex-13Filter Holder(MILLIPORE 
LTD.) （写真1〕． 内lζ 入れた Dacron製 Mesh
(35μ x35μ）を血液5ccを一定時間（ 1分間〕を要
して通過させた後IζFilter 〈直径9mm〕上le捕捉され







































j Heparinized Blood. Citrated Blood. 
N=6. N=6 
0. hour 25.8±12.6 0.0± 0.0 
1. 219.7土25.8 0.2± 0.4 
3. 230.5土 4.4
5. 127.0±50.6 0.5± 0.8 
24. 231 < 3.8± 4.0 











o hour , 22.3土2.19
1 ' 12.9土3.20
3 i 13.8±2泊
5 I 13.7+4.54 
24 I 5.4±0.55 
3 days I / 



























































6 i 3 5 24h剖悶 3 7ctay詰
Time. 



































































Emboli Volume. , 




















(2) Temptrol Q-130 (Bentley Labs.) を用いて血
液300cc中lζ31/minの割合で酸素を吹送し酸素加を
行った．回路としては循研製のものを用い全長 lmと
し，ポンプは 2Rollerの Micropump(Pemco Labs.〕
を使用し 50cc/minの割合で血液循環を行なった．
(3) Lande’－Edwards Membrane oxygenator (1M2〕
























! Emboli Volume in Blood-Oxygenation. 
Bubb日正てσ~－S Temptrol l Lande’－Ed-
in Flask. Q-130. I wards (IM2) 
N=6 N=6 I N=6 
omin 1.4±14.1 1.4士 2.6I 0.8± 1.3 
1 207.4± 7.3 221.2+6.81 ' 4.8土 1.8
5 199.0±12.5 153.8+25.5 52.0+22.l 
10 221.4± 10.1 57.0+18.0 8.4土 7.6
30 179.2±24.l ' 42.8±19.7 ' 2.8± 4.8 
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図6各種酸素加装置に於ける Microemboh


















Ii. (in vitro), ( 3例〉，

























Swinnex-13 Filter Holder lζ入れた Dacron製Me-
sh (35r~ x 35μ) ICて採取した．補助循環及び関心
術，体外循環中の Emboliは動脈回路lζ挿入した．
Barrier Blood Filter (Johnson & Johnson）にて採
取した．
201 ＜：；でいとk










（犬） (in vitro) 
(Temptrol: Temptro!Q-130使用群 ） 









（犬） (in vitro) 
Bubbling (Oz〕in Temptorol Q 130. Lande’－Edwards (lMZ〕
Flask. N=6. N=6. N=6. 
(X 104) Leucocyte. cx：~~t L…yte I (X104) Leucocyte. Platelet. Pla Platelet. 
0 (min): 
26.2+3.9 14600土4100 21.6+5.l 14700土3000 25.2+3.0 15500土3200
10 11.3±2.5 ／／ 12.4土2.1 ／／ 22.2士1.2 ／／ 
30 16.5+5.6 ／／ 12.0+1.3 ／／ 16.5土2.3 〆／／ 
60 20.5±4.0 8800±3600 12.6±4.0 制00±2000I 13.5土1.2 10000土2500
! Mean±IS.D. 
一一一一一一一 －ー－ もー『E ， ー』一一


















































しているのがみられる（写真9' 10) . 
写真 2 Mesh (35μ X 35μ) Iζ捕捉された
Microemboli. 
直径品加Oμ.ACD保存血20時間． （人〉




写真 5 へパリン保存血（20時間〕中lζ生じた Microemboli築後のJ!<Ili〔人）（走ふι日1 Jllli,'1 I 
写真 6 H写真5＂の強拡大（人） 3000倍















Sudan il染色性によって， ζれら Emboliを検討
すると，表5の如く保存血中の Emboli及び血液酸素
加過程の Emboliは人，犬共tc全て Sudanm.陰性





























症例は体重 10～25同の Vs D患者lζ限定し膜型人
工肺使用群6例，気泡型人工肺使用群6例の計12例に
ついて検討した．





表 5 各種血液中に存在する Microernboliの性状。（人及び犬〉
Emboli 
Stored Blood. (Dog〕





In Partial Perfusion. 
〔Dog)




S叫 nII. I Fibrin Stain. I Thin La戸rChrom吋
Stain. I (PT AH) Phospho 
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SF P測定装置には SwankSFP apparatus (Control 






表 6 体外循環各時期に於けるSFP1直 気泡型人工肺（TemptrolQ」10〕及び
膜型人工肺（Lande’－Edwards3M2〕に於ける比較。 （人〕
Screen Filtration Pressure. （皿Hg〕
N=6 N二 6
Temptrol Q-110. Lande'-Edwards. ( 3 M2) 
Stored Blood. (ACD〕 618.3士32.5 532.7±104.9 
トiltration. 54.3± 4.0 55.7± 14.4 (BARRIER Blood Filter〕
Recirculation Start. 30.3+ 2.0 32.0± 0.0 
Recirculation of. 68.3+13.7 42.3+ 2.5 
Bypass Start. 1 min. 105.0土10.1 54.7+ 12.9 
一一一一
5 minutes on Bypass. 33.3+ 1.5 25.3± 6.1 
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EDWARDS. I 23.3土 2.2. I 19.8土0.5
3M2x 1 
SFP （阻Hg)
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Temptrol: Temptrol Q 110使用鮮 l
表 8 気泡型人工肺（TemptrolQ 110）及び膜型人工肺（Lande’－Edwards3M2）を使用した
体外循環中及び体外循環後の血小板，白血球及びへ7 トタリノトi直の比級。 （人〉
TEMPTROL Q 110. 
N=5 
-- lPLATELET1 LEUCO , 
1 , i CYTE. i ー
｜ （×104) I c×103) I c初
Operation Start. I 26.6土8.9 i 8.3:2.3 40.0土2.5
Heparinization. 30.3土3.7
Bypass Start. 13.2土2.4 5.2土2.0 27.2土1.5
Bypass of. 9.0こl二3.6 11.4±3.2 28.1土2.1
Postoperation. 0 hour. 13.5±3.8 30.1土3.3
Postop. 3 hours. 15.5工2.9
Postop. 6 hours. 13.5ェ2.1 20.3ト2.7 32.5±2.7 
Postop. 24 hours. 12.8土2.0 32.0主2.5
Postop. 48 hours. 7.3土2.6 35.5土3.0
Postop. 72 hours. 10.2土2.0 36.3土2.5
Mean ± IS. D. 
I LANDE叩 WARDS.3M2 
.i N= 5 
[!PLATELET.¥ LEU~？，；.＿＂＇ Ht. 
It （×104〕 ｜ （×叩勺 （船
30.4±6.9 6.6+ 1.7 38.1±3.2 
30.6+5.4 
11.9± 1.3 3.8±6.8 26.6±1.5 





























































Bypass (10 min),[ 
Neutralization i' 
with Protamine.! 
(10 min) 1 
Postneutrah- ! 
zalion I 
1 hour. I 
3 hours. I 
6 hours. I 
24 hours. 1 


















VS D. 8～20kg. 
Heparin . 3 mg/ kg. 
Protamine : 7 I昭Ikg. 
Bypass Duration: 1 hour. 























肺としては TemptrolQ-130 ( 4例〕とLande’主dwa-



































































I EMBOLISM in Dog. OXYGENATOR. I KIDNEY. 
1. ! Tempt叫 Q・1so. I! 
















Preoxygenation : 1 hour. 
Partial Perfusion : 2 hours 













ちに heparinize ( 5 mg/lOcc）し SFPを測定
しSOmm Hg以下であるととを確認した後， 直ちに































Plasma A. ! 

















及ぼす影響。（大） (in vitro) 
Plasma free Hb. I SF P. 
(mg I di) (mmHg) 
N=6 N=6 
Control. 50.0± 5.0 35.2土12.8
5.mm. 94.5二 5.5 36.5±12.8 
10. 115.0土 44.0 38.0土14.0
15. 198.0± 27.0 41.5±17.5 
30. 940.0± 40.0 186.5±18.5 
45. 1130.0± 100.0 200.5土24.5















0 1000 2000 3000 
Plasma fre Hemoglobon (mgtdl I 












球成分，特l乙血小板を主体とした Emboliの定量ICは ζの種の Emboliのもう一つの発生源としては，体
Swank25lの開発したSF P法が一般に広く用いられて 外循環回路内の酸素加装置をあげるζとが出来る，
いる．著者も人の体外循環中の Emboli測定lζSF P Ashmore7＇は犬の血液を用いた invitroの実験で，団
法を用いたが， ζの測定法の手lj点はへ7 トクリソト． 転円盤型人工肺が形成するとの種 Microemboliを S
及び血液の viscocitylζ影響されるととなく 26'Emboli F P法l乙て観察し，その経時的増加を立証している．
量を鋭敏に測定し得るととである。一方乙れの有する 著者も前述の測定法で，犬血液を用いた invitroの回
欠点としては Emboliの性状，形，大きさが観察出来 路lζ於て，気泡型人工肺と膜型人工肺について夫々そ
ない事，及び大型で而も多量の Emboliを含有する血 の経時的 Emboli形成量を比較検討した結果，前者は
液では，測定誤差が大きくなるという乙とである． 後者lこ較べて著しく多量の Emboliを短時間内lζ形成
一方著者の考案した測定法はやや大型の Emboliを せしめることを立証した． 乙のととは Microemboli
多量に有する検体の測定lこも適して居り，而も顕鏡し の形成は血液と酸素との直接の接触によるものと考え





憾みがある．最近これと類似した方法で Dutton14Jも の実験成績は Ashmoreの報告した回転円盤型人工
体外循環，流血中の Emboli量を測定している． 1市，酸素吹送時の Emboli形成ノfターンとは全く異っ
( Il ) Microemboliの発生源 たものであった．
体外循環中lとみられる血小板を主体とする Micro・ Ashmoreの場合，それが直線的 lζ上昇したのに対
emboliの由来としては， 2種あるように恩われる．そ し，著者の成績では，気泡型人工肺で酸素加を開始す




c D保存血の2種類があるが，Emboliの含有置を前述 この減少は，回路を有しない Flask内での気泡型
の著者が考案した測定法でみる限りに於いては，クエ 酸素加によって得られた実験成績から考え，Emboliが
ン酸保存血の方がへノ〈リン保存血よりも少ない．乙の 回路内［こ捕捉されている ζとにその原因を求めざるを
乙とは Swank27＇が SF P法lζて既IC指摘していると 得ない． 特lζTemperol人工肺の如くその内部に除
ζろであるが著者の測定lこより，保存期間， 1時間で 泡装置と Meshを有するものでは ζの可能性が大で
既に両者間IC歴然とした差を生じるに至る乙とが判明 ある．又，第2の原因として考えられるものとして，
した． 一度形成された Aggregatesの崩壊をあげる ζとが出
血球成分と Emboliとの関連で Swank等は白血球 米る.Flask内の酸素加過程で認められた開始後30分







板減少の原因を CopleyZBJ等は Heparinそのものの れ，その後60分まではほぼ平衡状態を持続したが，乙
作用によるものとしているが，Perkinson29＇はHeparin の急峻な血小板減少期は Emboliの多量発生時期とよ
量の不足によるとし，更に Wright3oiは容器表面への く一致していた，従って， ζの減少は主として，血小






















































































ζの Embolismが invitroの回路内でみられた Rabiner制が報告したように，再度，血小叙は変化し







に， 犬体外循環の流血中の Emboliがズダン弱陽性で あろう．
あったところから，同起源性のものであるとすると， 乙の時期には又フィプリンの関与も充分考えられ，






み入れると Bender-GestaltVisual Moter Test及び って生じた溶血血祭は明らかに新鮮な血液内の血小板
腎機能の改善され得るに至るζ とを指摘している． を凝集せしめるように作用するととが確認された．
百）．人の体外循環後の血小板の状態 又， PlasmaFree HbとSF P値との聞には明らかな
最近の塚田加の報告lζよると，ガラスビーズカラム 正の相関関係（r=0.883）が認められた．
による血小板粘着能測定法では，粘着能だけでなく凝 現在，小児科領域Iζて問題になっている Hemolytic
集能の一部が測定結果lζ含まれるととをビーズ表面の Uremic Syndrome5引の本態を ConsumptionCoagu-
走査電顕学的観察で明らかにしている．又ζの測定法 lopathyと考えるH寺56九溶血がその Triggerlとなって
では，へパリンによる粘着能，凝集能の低下は認めら いる乙と56）町時）は充分に考えられる．又特発性高脂血






集能の著しい低下が認められた． ζのζとから次の事 現在，体外循環中の Microemboliの除去のために微




もののみが血液中を circulateしているととを示唆し 生じる HormonalAgentsの問題，体外循環後の血小
ている． 板機能低下の問題及び FatEmboli等とも併せ考え，


















































































1) Owen, G., Adams, J. E., McElhanon, F. M. and 
Y ongblood, R. W . Experimental alterations of 
certain colloidal properties of blood during 
cardiopulmonary bypass. J. Appl. Physiol., 14: 
947, 1959. 
2〕 Miller,J. A., Fonkalsrud, E.W., Latta, H. L. 
356 日・外・宝第43巻第5号（昭和49年9月）
and Mainey, ].V., Jr.: Fat embolism associated 
with extracorporeal circulation and blood 
transfusion. Surgery., 51: 448, 1962. 
3) Helmsworth, J. A., Gall, E. A., Perrin, E. V., 
Braley, S.A., Flege, J.B.,Jr., Kaplan, S., Keirle, 
A. M. and DeForest, D.: Occurrence of emboli 
during perfusion with an oxygenator pump. 
Surgery., 53: 177, 1963. 
4〕 Swank,R. L., Hirsch, H., Breuer, M. and 
Hissen, W. . Effect of glass wool filtration on 
blood during extracorporeal circulation. Surg. 
Gyn. Obst., 117: 547, 1963. 
5) Swank, R.L. and Porter, G. A.: Disappearance 
of microemboli transfused into patients during 
cardiopulmonary bypass. Transfusion., 3:192, 
1963. 
6 ) Allardyce, D. B., Yoshida, S. H. and Ashmore, 
P.G.: The importance of microembolism in the 
pathogenesis of organ dysfunction caused by 
prolonged use of the pump oxygenator. J. 
Thorac. Cardiovasc. Surg., 52: 706, 1966. 
7) Ashmore, P. G., Svitec, V. and Ambrose, P.: 
The incidence and effects of particulate agg-
regation and microembolism in pump-oxygena-
tor system. ]. Thorac. Cardiovasc. Surg., 55：・
691, 1968. 
8) Osborn, ].]., Swank, R.L., Hill, ].D., Aguilar, 
M.]. and Gerbode,F.: Clinical use of a dacron 
wool filter during perfusion for open-heart 
surgery. ]. Thorac. Cardiovasc. Surg., 60: 575, 
1970. 
9) Hill, JD., Osborn, ].]., Swank, R.L., Aguilar, 
M.]., Lanerolle, P. and Gerbode,F ..・Experience
using a new dacron wool filter during extra-
corporeal circulation. Arch. Surg., 101: 649, 
1970. 
10) Rittenhouse, E.A., Hessel, E. A.,Ito, C.S. and 
Merendino, K. A.: Effect of dipyridamole on 
microaggregate formation in the pump oxyge-
nator. Ann. Surg., 175: 1, 1972. 
11) Egeblad, K., Osborn, ].]., Hill, ].D. and Ger-
bode, F.: Blood filtration during cardiolpulmo-
nary bypass. ].Thorac. Cardiovasc. Surg., 63: 
384, 1972. 
12) Ashmore, P. G., Swank, R. L., Gallery, R., Am-
brose, P.and Prichard, K.H.: Effect of dacron 
wool filtration on the microembolic pheno-
menon in extracorporeal circulation. ]. Thorac. 
Cardiovasc. Surg., 63: 240, 1972. 
13〕 Lande’， A.].,Carlson, R. G., Patterson, Jr., 
Baxter, ]. and Lille)1同i,c.w .・ Cardiacsurgery 
with disposable membrane lungs. Trans. Amer. 
Soc. Artif. Int. Organs., XVIII: 532, 1972. 
14) Dutton, R.C. and Edmunds, L.H., Jr.: Measu-
rement of emboli in extracorporeal perfusion 
systems.]. Thorac. Cardiovasc. Surg., 65: 523, 
1973. 
15) Hollenberg, M., Pruett, R. and Thal, A.: Va-
soactive substances liberated by prolonged 
bubble oxygenation. J. Thorac. Cardiovasc. 
Surg., 45: 402, 1963. 
16) Yong, N. K., Eiseman, B., Spencer, F. C. and 
Rossi, N.: Increased pulmonary vascular re-
sistance following prolonged pump oxygenation. 
]. Thorac. Cardiovasc. Surg., 49: 580, 1965. 
17) Replogle, R., Levy, M., Dewall, R.L. and Lil-
ehei, R. C.: Catecholamine and serotonin res・ 
ponse to cardiopulmonary bypass. ]. Thorac. 
Cardiovasc. Surg., 44: 638, 1962. 
18) De Vries, W. C., Kwan-Gett, C. S. and Kolff, 
W.J. : Consumptive Coagulopathy, Shock, and 
artificial heart. Trans. Amer. Soc. Artfi. Int. 
Organs., XVI: 29, 1970. 
19〕 Hershgold,E.]., Kwan-Gett, C.S., Kwai,]. and 
Rowley, K . Hemostasis, coagulation and the 
total artificial heart Trans Amer. Soc. Artif. 
Int. Organs., XVIII: 181, 1972. 
20〕 安永幸二郎：血小板粘着能．臨床検査，16:220, 
1972. 
21) Salzman, E.W. : Measurement of platelet ad・
hesiveness. ].Lab Clin. Med., 62：・ 724,1963. 
22〕 安永幸二郎：内科宝函投稿中．
23〕 Spencer,M.P., Lawrence, G.H., Thomas, G.I 
and Sauvage, L.R.: the use of ultrasonics in 
the determination of arterial aeroembolism 
during open-heart surgery. Ann. Thoracic. 
Surg., 8: 489, 1969. 
24) Simmons, E., Litchi, E., Dwyer, S., Rowley, B., 
Young, R., Mackenzie, ]. and Almond, C.H.: 
Detection of microparticles during cardiopul・ 
monary bypass by use of electronic devices. 
Adv. Cardiol., 6: 94, 1971. 
25) Swank, R.L., Roth, ].G.and Jansen,].: Screen 
filtration pressure method and adhesiveness 
and aggregation of blood cel. ]. Appl. Physiol., 
19(2): 340, 1964. 
26) Dhall, D. P. and Matheson, N. A.: Platelet 
aggregate filtration pressure-a method of mea-
suring platelet aggregation in whole blood. 
Cardiovasc. Res., 3: 155, 1969. 
27) Swank, R. L. . Alteration of blood on storge: 
Measurement of adhesiveness of“AGING” 
platelets and leukocytes and their removal by 
filtration. New Engl. J. Med., 265: 728, 1961. 
28) Copley, A.L. and Robb, T.P.: Studies on pla-
telets. I. The effect of heparin on the platelet 
count in vitro. Am. ]. Clin. Path., 12: 416, 1942. 
29) Perkins, H.' A., Osborn, ].]. and Ger bode, F.: 
体外循環中に生じる MicroemboliIr.関する研究 357 
The effect of heparin on the platelet count 
in vitro. Am. J. Path., 30: 397, 1958. 
30〕 Wright,H.P.: The adhesiveness of blood pla-
telets in normal subjects with varying con-
centrations of anticoagulants. J. Path. Bact., 
53・255,1941. 
31) Lee, W. H., Jr., Krumhaar, D., Fonkalsrud, 
E.W., Schjeide, 0.A. and Maloney J.V., Jr.: 
Denaturation of plasma proteins as a cause of 
morbidity and death after intracardiac opera-
tion. Surgery., 50: 29, 1961. 
32) Wright, E.S., Sari王ozy,E., Dobell, A.RC. and 
Murphy, D.R.: Fat globulemia in extracorpore-
al circulation. Surgery., 53: 500, 1963. 
33) Adkins, R. B. and Foster, J. H. Experimental 
study of the genesis of fat embolism Ann. 
Surg., 156: 515, 1962. 
34) Jenevein, E. P., Jr. and Weiss, D. L.: platelet 
microemboli associated with massive blood 
transfusion. Am. J. Path., 45: 313, 1964. 
35) Carlson, R.G., Lande’， A J., Landis, B., Rogoz, 
B., Baxter, J., Patterson, R.H. Jr., Stenzel, K. 
and Lillehei, C. W. , The LandeにEdwards
membrane oxygenator during heart surgery. J.
Thorac. Cardiovasc. Surg., 66: 894, 1973. 
36) 塚田理康，小川哲平：ガラスビーズへの血小板
粘着についてー走査電顕による検討ー． 臨床血
液，14: 777, 1973. 
37) 0’Brien, J. R., Schoobridge, S. M. and Finch, 
W.J.: Comparison of the effect of heparin and 
citrate on platelet aggregation. J. Clin. Path., 
22: 28, 1969. 
38) Leval, M., Hill, JD., Mielke, H., Bramson, M.L., 
Smith, C. and Gerbode, F.: Platelet kinetics 
during extracorporeal circulation. Trans. Amer. 
Soc. Artif. Int. Organs., XVIII: 355, 1972. 
39) Rabiner, S. R. and Friedman, L. H .・ Therole 
of intravascular haemolysis and the reticuloend-
othelial system in the production of a hyperco-
agulable state. Brit. J. Haemat., 14: 105, 1968. 
40) Hardaway, RふIf.: Disseminated intravascular 
coagulation in shock. Throb. Diath. Haemorrh. 
Suppl., 36 : 159, 1969. 
41) Hardaway, R. M.: Disseminated intravascular 
coagulation in experimental and clinical shock. 
Am. J.Cardiol., 20 : 161, 1967. 
42) Boyd, A.D., Engelman, R.M., Beaudet, R.L. and 
Lackner, H.: Disseminated intra vascular coagu-
lation following extracorporeal circulation. J. 
Thorac. Cardiovasc. Surg., 64 : 685, 1972. 
43〕 Abildgaard, C. F. : Recognition and treat-
ment of intravascular coagulation. J. Pediat., 
74: 163, 1969. 
44) Gans, H., Siegal, D. L., Lillehei, C. W. and 
Krivit, W. : Problem in hemostasis during 
open-heart surgery・ I. On the hypercoagula・ 
bility of blood during cardiac bypass. Ann. 
Surg., 156 : 19, 1962. 
45〕 Rodriguez-Erdmann,F. . Bleeding due to in・
creased intravascular blood coagulation. Ne"' 
Engl. J. Med., 273 : 1370, 1965. 
46) Verstraete, M., Vermylen. C., Vermylen, J. 
and Vandenbrucke, J. Excessive consumption 
of blood coagulation components as cause of 
hemorrhagic diathesis. Am. J. Med., 38 : 899, 
1965. 
47) 二之宮景光．血管内凝固症候群．ー外科領域一，
日本臨床 31: 822, 1973. 
48) Margaretten, W. : Local tissue damage in di・
sseminated intravascular clotting. Am. J. Car-
diol., 20 185, 1967. 
49) Lasch, H. G., Heene, D. L., Huth, K. and 
Sandritter, W. Pathophysiology, Clinical mani-
festations and therapy of consumption-coagu・ 
lopathy. Am. J. Cardiol., 20 : 381, 1967. 
50) McKay, D. G. and Miiller-Berghaus, G. ・ The-
rapeutic implications of disseminated intra-
vascular coagulation. Am. J. Cardiol., 20 : 392, 
1967. 
51〕 Corrigan,J.J., Jr., Ray, W. L. and May, N. : 
Changes in the blood coagulation system ass-
ociated with septicemia New Engl. J. Med., 
279 : 851, 1968. 
52) Rosenberg, J. C., Hawkins, E. and Mammen, 
E.: Hypovolemia-induced intravascular coagula-
tion and platelet aggregation in renal trans・
plants. Trans. Amer. Soc. Artifi. Int. Organs., 
XVIII : 283, 1972. 
53) Hellem, A J. : The adhesiveness of human 
blood platelets in vitro. Scand. J. Clin. Lab. 
Invest., 12 : suppl. 51, 1960. 
54) Gaarder, A., Jonsen, J., Laland, S. Hellem ,A.J. 
and Owren, P.A.: Adenosine diphosphate in 
red cells as a factor in the adhesiveness of 
human blood platelets. Nature., 192 : 531, 
1961. 
55) Gasser, C., and Gautier, E., Annemarie Steck, 
Siebenmann, R. E. u. Oechslin, R. : H通moly・
tisch-uramische Syndrom : Bilaterale h’ieren-
rindennekrosen bei akuten erworbenen hamoly-
tischen Anamien. Schweiz. Med Wschr., 85: 
905, 1955. 
56) Kiinzer, W. u. Aalam, F .. Zur Heparinbehand-
lung des akuten Hamolytisch-uramischen Syn-






床血液 9: 751, 1968. 
58) Brain, M. C. : Microangiopathic hemolytic 
anemia. New Engl. J. Med. 281 : 833, 1969. 
59) Campbell, S. and Carre, I. J. : Fatal haemolytic 
uraemic syndrome and idiopathic hyperlipae-
mia in monozygotic twins. Arch. Dis. Childh., 




61〕 O’Brien,].R. : Fat ingestion, blood coagulation 
and atherosclerosis. Am. ]. M .Sc., 234 : 373, 
1957. 
62〕 Moolten,S.E., Vroman, L., Vroman, G.M.S. and 
Goodman, B. : Role of blood platelets in throm-
boembolism. Arch. Int. Med・, 84: 667, 1949. 
63) Moolten, S.E., Jennings, P.B. and Solden, A : 
Dietary fat and platelet adhesiveness in arte-
riosclerosis and diabetes. Am. ]. Cardiol., 11: 
290, 1963. 
64) Philp, P.B. and Wright, H.P. : Effect of ade-
nosine on platelet adhesiveness in fasting and 
lipaemic bloods. Lancet., 31 : 208, 1965. 
